A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities

Thaddeus W W Pace, Christine Marcelle Heim

Research output: Contribution to journalReview article

171 Citations (Scopus)

Abstract

Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalBrain, Behavior, and Immunity
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Psychoneuroimmunology
Post-Traumatic Stress Disorders
Comorbidity
Immune System Diseases
Lymphocyte Count
Veterans
Skin Tests
Natural Killer Cells
Glucocorticoids
Catecholamines

All Science Journal Classification (ASJC) codes

  • Immunology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

@article{dbf6795ea0ae42dba73a86d079221c0f,
title = "A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities",
abstract = "Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8{\%} in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.",
author = "Pace, {Thaddeus W W} and Heim, {Christine Marcelle}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.bbi.2010.10.003",
language = "English (US)",
volume = "25",
pages = "6--13",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",
number = "1",

}

A short review on the psychoneuroimmunology of posttraumatic stress disorder : From risk factors to medical comorbidities. / Pace, Thaddeus W W; Heim, Christine Marcelle.

In: Brain, Behavior, and Immunity, Vol. 25, No. 1, 01.01.2011, p. 6-13.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A short review on the psychoneuroimmunology of posttraumatic stress disorder

T2 - From risk factors to medical comorbidities

AU - Pace, Thaddeus W W

AU - Heim, Christine Marcelle

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

AB - Posttraumatic stress disorder (PTSD) is a serious and debilitating condition with a prevalence rate of approximately 8% in the United States. Given the number of veterans returning from conflicts around the globe with PTSD, and the substantial number of civilians experiencing traumas, new perspectives on the biology of PTSD are needed. Based on the concept that PTSD is a disorder of stress response systems, numerous studies have suggested changes in hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system function in patients with PTSD. Given that both glucocorticoids and catecholamines exert powerful effects on the immune system, it is surprising that relatively few studies have examined immune changes in patients with PTSD. Moreover, patients with PTSD are known to have increased rates of comorbidity with somatic disorders that involve immune and inflammatory processes. Patients with PTSD have been found to exhibit a number of immune changes including increased circulating inflammatory markers, increased reactivity to antigen skin tests, lower natural killer cell activity, and lower total T lymphocyte counts. Studies with humans and rodents suggest that certain proinflammatory cytokines are able to induce neurochemical and behavioral changes that resemble some key features of PTSD. This short article reviews immune alterations in PTSD, and considers possible mechanisms by which such changes may be related to neuroendocrine alterations and medical comorbidities of PTSD.

UR - http://www.scopus.com/inward/record.url?scp=78649324180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649324180&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2010.10.003

DO - 10.1016/j.bbi.2010.10.003

M3 - Review article

C2 - 20934505

AN - SCOPUS:78649324180

VL - 25

SP - 6

EP - 13

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

IS - 1

ER -